Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …

Prostate cancer (PCa) is one of the most commonly diagnosed malignancies and among the
leading causes of cancer-related death worldwide. It is a highly heterogeneous disease …

Prostate cancer has a long disease history and a wide variety and uncertainty in individual
patients' clinical progress. In recent years, we have seen a revolutionary advance in both …

Prostate cancer (PCa) is one of the most common cancers in European males. Although
therapeutic approaches have changed in recent years, and several new drugs have been …

目的分析2015 年中国前列腺癌的发病与死亡情况, 为前列腺癌的防控提供依据.
方法对国家癌症中心收集的全国501 个肿瘤登记处上报的2015 年数据进行质量审核和评估 …

Prostate cancer is a substantial public health problem worldwide. It is the most common
neoplasm among men and third-ranked cause of cancer death in Europe, with almost …

The present study aimed to investigate the relationship between BMI and the prostate
cancer (PCa) risk at biopsy in Italian men. Retrospective analyses of the clinical data of …

Prostate cancer (PCa) remains the most common cancer in men. The proportion of all PCa
attributable to high-risk hereditary factors has been estimated to 5–15%. Recent landmark …

Prostate cancer is a genetic disease. While next generation sequencing has allowed for the
emergence of molecular taxonomy, classification is restricted to the nuclear genome …

Recent advances in whole-genome and transcriptome sequencing of prostate cancer at
different stages indicate that a large number of mutations found in tumors are present in non …